Breastfeeding reduces the risk of breast cancer: A call for action in high‐income countries with low rates of breastfeeding
Top Cited Papers
Open Access
- 26 September 2022
- journal article
- review article
- Published by Wiley in Cancer Medicine
- Vol. 12 (4) , 4616-4625
Abstract
Women in the UK have a 15% lifetime risk of developing breast cancer. Like other high‐income countries, women in the UK are having children later in life which increases their risk. The risk of breast cancer is reduced by 4.3% for every 12 months of breastfeeding, this is in addition to the 7.0% decrease in risk observed for each birth. Breastfeeding reduces the risk of Triple‐Negative Breast Cancer (20%) and in carriers of BRCA1 mutations (22–55%). The mechanisms of reduced risk as a result of pregnancy are related to changes in RNA processing and cellular differentiation. The UK has a low rate of breastfeeding (81%) and this is contrasted to countries with higher (Sweden, Australia) and lower rates (Ireland). The low UK rate is in part due to a lack of experience in the population, todays grandmothers have less experience with breastfeeding (62%) than their daughters. An estimated 4.7% of breast cancer cases in the UK are caused by not breastfeeding. The UK only has 43% of maternity services with full Baby‐Friendly accreditation which promotes compliance with the WHO ‘Ten Steps to Successful Breast Feeding’. Legislation in the UK and Europe is far short of the WHO Guidance on restricting the advertising of formula milk. Expansion of the Baby‐Friendly Hospital Initiative, stricter laws on the advertising of formula milk and legislation to support nursing mothers in the workplace have the potential to increase breastfeeding in the UK. Women with a family history of breast cancer should particularly be supported to breastfeed as a way of reducing their risk.Keywords
This publication has 65 references indexed in Scilit:
- Factors associated with breastfeeding in England: an analysis by primary care trustBMJ Open, 2013
- Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20–44 years of ageBreast Cancer Research and Treatment, 2012
- Defining the genomic signature of the parous breastBMC Medical Genomics, 2012
- Role of Estrogen Receptor Signaling in Breast Cancer MetastasisInternational Journal of Breast Cancer, 2011
- Characterization of a Genomic Signature of Pregnancy Identified in the BreastCancer Prevention Research, 2011
- Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancerJournal of Medical Genetics, 2011
- Evidence That an Early Pregnancy Causes a Persistent Decrease in the Number of Functional Mammary Epithelial Stem Cells—Implications for Pregnancy-Induced Protection Against Breast CancerStem Cells, 2008
- Breast Cancer Risk and Hormone Receptor Status in Older Women by Parity, Age of First Birth, and Breastfeeding: A Case-Control StudyCancer Epidemiology, Biomarkers & Prevention, 2008
- Molecular Characterization of Human Breast Tumor Vascular CellsThe American Journal of Pathology, 2008
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003